Where would you like to sign in?

Zynex, Inc. Schedules Fiscal Year 2010 Earnings Release and Webcast

LONE TREE, CO--(Marketwire - March 7, 2011) - ZYNEX, INC. (OTCBB: ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announced today that it will be hosting an investor webcast, Thursday, March 10, 2011 at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time to discuss the Company's fiscal year 2010 results.

The Company expects to release fiscal year 2010 financial and operating results on Thursday, March 10, 2011, prior to the market open.

Webcast Details: Thursday, March 10, 2011 at 9:00 a.m. MT - 11:00 a.m. ET To register and participate in the webcast, interested parties should click on the following link approximately 10-15 minutes prior to the webcast: http://www.visualwebcaster.com/event.asp?id=77408

Please note: questions can only be submitted via the webcast user interface. Parties without access to the internet may join the presentation in listen only mode by dialing the toll free number provided below.

About Zynex
Zynex, Inc. (founded in 1996) engineers, manufactures, markets and sells its own design of medical devices in three subsidiaries. Zynex Medical is a provider of electrotherapy products for home use, Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals and Zynex NeuroDiagnostic develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets. Zynex Medical's product line is fully developed, FDA-cleared, commercially sold, and has been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex Monitoring Solutions and Zynex NeuroDiagnostic are currently both in the development stages without any significant revenues. For additional information please visit: http://www.ir-site.com/zynex/default.asp.

Safe Harbor Statement
Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage additional sales representatives, the success of such additional sales representatives, the need to obtain FDA clearance and CE marking of new products, the acceptance of new products as well as existing products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on the reimbursement from insurance companies for products sold or rented to our customers, acceptance of our products by health insurance providers, our dependence on third party manufacturers to produce our goods on time and to our specifications, implementation of our sales strategy including a strong direct sales force, the uncertain outcome of pending material litigation and other risks described in our filings with the Securities and Exchange Commission including the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2009.